Upregulated SPRY4-IT1 and ANRIL in NSCLC tumor tissues has been found to be a biomarker for a poor prognosis of NSCLC (Pan et al. 2015; Hu et al. 2016). Here, SPRY4 is linked to non-small cell lung carcinoma.